Company behind new Covid-19 treatment 'cannot get meeting with Government'

Celltrion Healthcare, the makers of Regkirona, sent a letter of complaint to Tánaiste Leo Varadkar

Celltrion Healthcare complained in a letter to Tánaiste Leo Varadkar that it has unsuccessfully 'attempted to engage' with the Department of Health and the HSE to make the treatment available. Picture: Gareth Chaney/Collins

The company behind a new Covid-19 anti-viral treatment which could relieve pressure on the country's intensive care unit (ICU) beds claims it has not been granted meetings with senior Government officials.

Regkirona is a new anti-viral treatment, approved by the European Medicines Agency and adopted by other EU countries, and has been shown to radically reduce the need for ICU care in Covid patients who have been treated.